Abstract
A recent study associated early proliferative or fibrotic diffuse alveolar damage with mortality in acute respiratory distress syndrome. We highlight four interpretive concerns: phenotype status was assigned at biopsy after follow-up began, creating potential immortal-time bias; a single biopsy cannot measure pathological velocity; sparse and imbalanced phase-by-timing cells limit component-specific inference; and concurrent physiological measurements complicate causal interpretation. Until delayed-entry survival and phase-specific sensitivity analyses are reported, the phenotype is better viewed as early advanced-phase histology than evidence of accelerated pathology.